Jacques Dumas Insider Trading $TTPH TETRAPHASE PHARMACEUTICALS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Jacques Dumas.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jacques Dumas. Jacques Dumas is EVP, Chief Scientific Officer in IDENIX PHARMACEUTICALS INC ($IDIX) and Chief ScientificOfficer in TETRAPHASE PHARMACEUTICALS INC ($TTPH).
Jacques Dumas in TETRAPHASE PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Jacques Dumas: Chief ScientificOfficer
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jan 18 2019
$TTPH Market Capitalization: $155.73M
$TTPH Previous Close: $4.18
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Jacques Dumas in TETRAPHASE PHARMACEUTICALS INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 18 2019 | TTPH | TETRAPHASE PHARMAC ... | Dumas Jacques | Chief ScientificOff ... | Option Exercise | A | 0.00 | 140,000 | 0 | 140,000 | |
| Jan 18 2019 | TTPH | TETRAPHASE PHARMAC ... | Dumas Jacques | Chief ScientificOff ... | Option Exercise | A | 0.00 | 40,000 | 0 | 40,000 | |
| Jan 10 2019 | TTPH | TETRAPHASE PHARMAC ... | Dumas Jacques | Chief ScientificOff ... | Sell | S | 1.60 | 7,497 | 11,995 | 0 | 7.5 K to 0 (-100.00 %) |
| Apr 04 2018 | TTPH | TETRAPHASE PHARMAC ... | Dumas Jacques | Chief ScientificOff ... | Option Exercise | A | 0.00 | 40,000 | 0 | 40,000 | |
| Jan 31 2018 | TTPH | TETRAPHASE PHARMAC ... | Dumas Jacques | Chief ScientificOff ... | Option Exercise | M | 3.69 | 8,750 | 32,288 | 105,000 | |
| Jan 31 2018 | TTPH | TETRAPHASE PHARMAC ... | Dumas Jacques | Chief ScientificOff ... | Sell | S | 6.22 | 8,750 | 54,425 | 0 | 8.8 K to 0 (-100.00 %) |
| Jan 31 2018 | TTPH | TETRAPHASE PHARMAC ... | Dumas Jacques | Chief ScientificOff ... | Buy | M | 3.69 | 8,750 | 32,288 | 8,750 | 0 to 8.8 K |
| Jan 19 2018 | TTPH | TETRAPHASE PHARMAC ... | Dumas Jacques | Chief ScientificOff ... | Option Exercise | A | 6.24 | 140,000 | 873,600 | 140,000 | |
| Jan 19 2018 | TTPH | TETRAPHASE PHARMAC ... | Dumas Jacques | Chief ScientificOff ... | Option Exercise | A | 0.00 | 40,000 | 0 | 40,000 | |
| Jan 19 2018 | TTPH | TETRAPHASE PHARMAC ... | Dumas Jacques | Chief ScientificOff ... | Option Exercise | A | 6.24 | 140,000 | 873,600 | 140,000 | |
| Jan 19 2018 | TTPH | TETRAPHASE PHARMAC ... | Dumas Jacques | Chief ScientificOff ... | Option Exercise | A | 0.00 | 40,000 | 0 | 40,000 | |
| Jan 11 2018 | TTPH | TETRAPHASE PHARMAC ... | Dumas Jacques | Chief ScientificOff ... | Sell | S | 6.21 | 7,167 | 44,507 | 0 | 7.2 K to 0 (-100.00 %) |
| Nov 02 2017 | TTPH | TETRAPHASE PHARMAC ... | Dumas Jacques | Chief ScientificOff ... | Option Exercise | M | 3.69 | 8,750 | 32,288 | 113,750 | |
| Nov 02 2017 | TTPH | TETRAPHASE PHARMAC ... | Dumas Jacques | Chief ScientificOff ... | Sell | S | 6.03 | 8,750 | 52,763 | 0 | 8.8 K to 0 (-100.00 %) |
| Nov 02 2017 | TTPH | TETRAPHASE PHARMAC ... | Dumas Jacques | Chief ScientificOff ... | Buy | M | 3.69 | 8,750 | 32,288 | 8,750 | 0 to 8.8 K |
| Aug 24 2017 | TTPH | TETRAPHASE PHARMAC ... | Dumas Jacques | Chief ScientificOff ... | Option Exercise | M | 3.69 | 17,500 | 64,575 | 122,500 | |
| Aug 24 2017 | TTPH | TETRAPHASE PHARMAC ... | Dumas Jacques | Chief ScientificOff ... | Sell | S | 6.00 | 17,500 | 105,000 | 0 | 17.5 K to 0 (-100.00 %) |
| Aug 24 2017 | TTPH | TETRAPHASE PHARMAC ... | Dumas Jacques | Chief ScientificOff ... | Buy | M | 3.69 | 17,500 | 64,575 | 17,500 | 0 to 17.5 K |
| Aug 21 2017 | TTPH | TETRAPHASE PHARMAC ... | Dumas Jacques | Chief ScientificOff ... | Sell | S | 5.86 | 7,155 | 41,928 | 0 | 7.2 K to 0 (-100.00 %) |
| Feb 01 2017 | TTPH | TETRAPHASE PHARMAC ... | Dumas Jacques | Chief ScientificOff ... | Option Exercise | A | 3.69 | 140,000 | 516,600 | 140,000 | |
| Feb 01 2017 | TTPH | TETRAPHASE PHARMAC ... | Dumas Jacques | Chief ScientificOff ... | Option Exercise | A | 0.00 | 30,000 | 0 | 30,000 |
Page: 1